HSCS Stock Analysis: Buy, Sell, or Hold?
HSCS - HeartSciences Inc. Common Stock
$2.18
0.10 (4.81%)
▲
5d:
-8.79%
30d:
-25.85%
90d:
+11.79%
HOLD
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Sep 10, 2026
Get Alerted When HSCS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: HSCS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: HSCS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: HSCS is currently trading at $2.18, which is considered oversold relative to its 30-day fair value range of $2.36 to $2.83.
Technical Outlook: Technically, HSCS is showing sideways momentum. Immediate support is located at $1.85, while resistance sits at $2.62. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+358.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, HSCS is showing sideways momentum. Immediate support is located at $1.85, while resistance sits at $2.62. The stock is showing strong short-term momentum, up 4.8% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.00 (+358.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.36 -
$2.83
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.8%)
- BULLISH: Trading 358.7% below Wall St target ($10.00)
- CAUTION: Recommendation downgraded due to -8.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$2.36 -
$2.83
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.85
Resistance Level
$2.62
Current Trend
Sideways
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.77
Wall Street Target
$10.00
(+358.7%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 02, 2026 7:53 AM ET
Data refreshes hourly during market hours. Next update: 8:53 AM
Data refreshes hourly during market hours. Next update: 8:53 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HSCS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$86 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$100 | 52 HOLD |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 60 HOLD |
